Lung Cancers Completed Phase 2 Trials for Docetaxel (DB01248)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00030810Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLCTreatment
NCT00003231Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung CancerTreatment
NCT00541099Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00281970Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryTreatment
NCT01443078Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)Treatment
NCT00301808Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment
NCT00970684Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT00660816Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00687297Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung CancerTreatment
NCT00673738Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)Treatment
NCT00449020Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerTreatment
NCT00278460Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00193323Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly PatientsTreatment
NCT00201825A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer PatientsTreatment
NCT00193453Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung CancerTreatment
NCT00193245Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung CancerTreatment
NCT00193427Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung CancerTreatment
NCT00222144Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung CancerTreatment
NCT00114192Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00103389Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00080080Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung CancerTreatment
NCT00077311Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00064012Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerTreatment
NCT00075374Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00059943Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate CancerTreatment
NCT00062439S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast TumorsTreatment
NCT00026156S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00030420Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00030407Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerTreatment
NCT00005868Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung CancerTreatment
NCT00003900Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerTreatment
NCT00004139Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00003762Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00003565Docetaxel in Treating Patients With Solid TumorsTreatment
NCT00003587S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00280735Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLCTreatment